TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Onkologia AB
Closing information (x1000 SEK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
1,197
|
1,477
|
1,441 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
970
|
1,274
|
1,290 |
| EBITDA |
957
|
1,260
|
1,224 |
| Total assets |
5,171
|
4,692
|
3,899 |
| Current assets |
1,207
|
1,592
|
1,495 |
| Current liabilities |
53
|
140
|
164 |
| Equity capital |
5,118
|
4,552
|
3,735 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
99.0%
|
97.0%
|
95.8% |
| Turnover per employee |
1,197
|
1,477
|
1,441 |
| Profit as a percentage of turnover |
81.0%
|
86.3%
|
89.5% |
| Return on assets (ROA) |
18.8%
|
27.2%
|
33.1% |
| Current ratio |
2277.4%
|
1137.1%
|
911.6% |
| Return on equity (ROE) |
19.0%
|
28.0%
|
34.5% |
| Change turnover |
-280
|
36
|
224 |
| Change turnover % |
-19%
|
2%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.